研報掘金|華泰證券:上調中國銀河目標價至10.31港元 投資收入增長是業績核心驅動力
華泰證券發表報告指出,中國銀河去年收入按年增長5.43%至354.71億元,淨利潤升27.31%至100.31億元,略低於業績快報預測的101億元。當中,去年第四季收入按年升2.75%至83.85億元,淨利潤升1.4倍至30.67億元。該行認爲,中國銀河投資收入增長是業績核心驅動力,預計未來整體經營穩健、機構業務發力。
考慮到市場景氣度回暖、公司資產負債表持續擴張,適當上調全市場日均成交額、公司投資收入等假設,該行預計公司2025至2027年每股盈利分別爲1.06、1.19及1.32元,對其目標價9.2港元上調至10.31港元,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.